Industry Shift Toward Early Production Fluid Selection Improves Medical Device Manufacturing Outcomes

Medical device manufacturers are increasingly recognizing the critical role that production fluid selection plays in product quality, regulatory compliance, and overall manufacturing efficiency.

Traditionally, fluids used for cleaning, coating, lubrication, and assembly have been selected later in the development process. However, this reactive approach often results in material compatibility issues, revalidation delays, increased regulatory scrutiny, and higher production costs.

A growing industry trend is shifting this approach earlier in the process, integrating production fluid choice into initial development planning.

By selecting fluids at the outset, manufacturers can better align materials, processes, and compliance requirements, reducing risk and improving performance across the product lifecycle.

Advanced solutions such as Tergo™ XCF2 Performance Fluid, Swellex™ Swelling Fluid, Duraglide™ Dry Lubricant, and Universal Carrier Fluid II are enabling manufacturers to support key process steps including surface preparation, precision assembly, lubrication, and coating delivery.

Industry experts note that early fluid choice delivers measurable benefits, including:
 

• Improved regulatory readiness 
• Enhanced material compatibility 
• Increased manufacturing efficiency 
• Greater product reliability 
• Reduced total lifecycle costs 

As device complexity and regulatory demands continue to increase, early production fluid planning is becoming a best practice for manufacturers looking to accelerate time to market while maintaining high quality standards.

Want to learn more about which fluid is right for you?

Talk with a MicroCare expert today.